Clinical Trials Sponsored by Oticon Medical

Total 56462 results

Orion Corporation, Orion Pharma

Completed

Phase I Pharmacokinetic Study (BF-BLOCK) (BF-BLOCK)

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers (PIFECO)

Pulmonary Disease, Chronic Obstructive | Asthma

United Kingdom, Finland
Orion Corporation, Orion Pharma

Completed

Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics (KINECO)

Asthma

United Kingdom
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability Study With Single Ascending Doses of ORM-12741

Healthy

France
Orion Corporation, Orion Pharma

Completed

Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables (Electro)

Stroke | Transient Ischemic Attack

Finland, Germany, Hungary, Sweden
Orion Corporation, Orion Pharma

Completed

Suitability of 11C-ORM-13070 as a PET Tracer

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis

Dermatitis, Atopic

Finland
Orion Corporation, Orion Pharma

Completed

Early Phase I Microdosing Study of ORM-14540 and ORM-12741

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Stalevo in Early Wearing-Off Patients (SEWOP)

Idiopathic Parkinson's Disease

United Kingdom, Denmark, Ireland, Finland, Germany, Sweden
Orion Corporation, Orion Pharma

Completed

Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741 (ALMAS)

Healthy Male Volunteers

Netherlands
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study With Repeated Doses of Stalevo

Pharmacokinetics

Finland
Orion Corporation, Orion Pharma

Completed

Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.

Parkinson's Disease

Germany
Orion Corporation, Orion Pharma

Completed

Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass

Coronary Heart Disease

Finland
Orion Corporation, Orion Pharma

Active, not recruiting

Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer (CYPIDES)

Prostate Cancer Metastatic

France, United Kingdom, Finland, United States
Orion Corporation, Orion Pharma

Terminated

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension (REFALS-ES)

Amyotrophic Lateral Sclerosis

Canada, United States, Australia, Germany, Belgium, Finland, Spain, Austria, Italy, France, Ireland, Netherlands, Sweden, United Kingdom
Orion Corporation, Orion Pharma

Completed

Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product (FORELLI)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler® (TESSA)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours (KIDES-203)

Solid Tumours

France, Finland, Spain, Italy, Denmark, United Kingdom
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax (Remo-Wax)

Cerumen Impaction of Both Ears

Lithuania
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) (COMPOC)

Parkinson's Disease

Finland, Germany, Hungary, Latvia
Orion Corporation, Orion Pharma

Completed

Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Ireland, Netherlands, United Kingdom, Germany
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic of Levodopa Study in Healthy Males

Parkinson Disease

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.

Heart Failure

Sweden
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Study to Evaluate Initiation of Stalevo in Early Wearing-off (SENSE)

Parkinson's Disease

Germany, Sweden, United Kingdom
Orion Corporation, Orion Pharma

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers (NOCIFIM)

Healthy

Germany
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability Study With Single Ascending Doses of ODM-102

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries

Pain

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries

Pain

Finland
Orion Corporation, Orion Pharma

Completed

Phase I Pharmacokinetic Study (SALBLOCK) (SALBLOCK)

Healthy Volunteer Study

Finland
Orion Corporation, Orion Pharma

Completed

Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens (PARTEST)

Parkinson's Disease

Finland, Sweden
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (Reco-Pilot)

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Levodopa Concentration Profile With Stalevo 75/125 mg (NEWSTA)

Parkinson's Disease

Finland
Orion Corporation, Orion Pharma

Completed

Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU) (Prodex)

Continuous Sedation in Initially Sedated Adults in ICU

Finland, United Kingdom, Belgium, Germany, Netherlands, Russian Federation, Switzerland
Orion Corporation, Orion Pharma

Completed

A PET Study With ORM-12741

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study of ORM-12741 in Healthy Volunteers

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741

Healthy

France
Orion Corporation, Orion Pharma

Completed

Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU (DEX PK)

Pharmacokinetics | Sedation

Finland
Orion Corporation, Orion Pharma

Completed

Peroral Levosimendan in Chronic Heart Failure

Heart Diseases | Chronic Heart Failure

Finland
Orion Corporation, Orion Pharma

Terminated

Dexmedetomidine for Continuous Sedation

Conscious Sedation

Finland, Switzerland
Burke Medical Research Institute
4D Motion Sports

Completed

Home Exercise With Wearable Sensors

Stroke | Hemiparesis

United States
Medical University of South Carolina
Ethicon, Inc.

Completed

A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICEL™ Fibrin Sealant in Thyroidectomy

Goiter | Thyroid Neoplasm
Ethicon, Inc.

Recruiting

POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)

Lung Neoplasms

United States, Hong Kong, Canada
Ethicon, Inc.

Recruiting

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

Pelvic Organ Prolapse

United States, Germany
Ethicon, Inc.

Recruiting

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

Stress Urinary Incontinence

Poland, United States, Italy, Switzerland
Ethicon, Inc.

Recruiting

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

Stress Urinary Incontinence

United States, Germany, Denmark, France, Austria, Sweden
Topcon Corporation

Completed

TRK-3 Conformance to Standards for Tonometers

Glaucoma

United States
Ethicon, Inc.

Terminated

Microwave Ablation in Chinese Patients With Lung Tumors

Cancer of the Lung

China
Topcon Corporation

Completed

TRK-3 Performance of Pachymetry

Normal

United States

Clinical Trials Sponsored by Oticon Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations